Literature DB >> 18838739

The emerging roles of PAF acetylhydrolase.

Thomas M McIntyre1, Stephen M Prescott, Diana M Stafforini.   

Abstract

Platelet-activating factor (PAF), a phospholipid autacoid with potent effects throughout the innate immune system, is selectively degraded by two small families of PAF acetylhydrolases (PAF-AHs). These Ca2+-independent phospholipases A2 display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains oxygen functions. Two of the PAF-AHs therefore are specific oxidized phospholipid phospholipases that reduce inflammation, but also remove oxidatively truncated phospholipids that induce apoptosis. The roles of these enzymes are manifold, and their separate and combined functions are now being addressed in model systems and clinical studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838739      PMCID: PMC2674695          DOI: 10.1194/jlr.R800024-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  50 in total

1.  Transfection of the plasma-type platelet-activating factor acetylhydrolase gene attenuates glutamate-induced apoptosis in cultured rat cortical neurons.

Authors:  Y Hirashima; H Ueno; K Karasawa; K Yokoyama; M Setaka; A Takaku
Journal:  Brain Res       Date:  2000-12-01       Impact factor: 3.252

2.  Identification of platelet-activating factor acetylhydrolase II in human skin.

Authors:  Mariangela Marques; Yong Pei; Michael D Southall; John M Johnston; Hiroyuki Arai; Junken Aoki; Takao Inoue; Holger Seltmann; Christos C Zouboulis; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2002-10       Impact factor: 8.551

3.  HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice.

Authors:  G Theilmeier; B De Geest; P P Van Veldhoven; D Stengel; C Michiels; M Lox; M Landeloos; M J Chapman; E Ninio; D Collen; B Himpens; P Holvoet
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

Review 4.  Platelet-activating factor acetylhydrolase (PAF-AH).

Authors:  Hiroyuki Arai; Hiroyuki Koizumi; Junken Aoki; Keizo Inoue
Journal:  J Biochem       Date:  2002-05       Impact factor: 3.387

5.  The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase.

Authors:  T W Kuijpers; J M van den Berg; A T Tool; D Roos
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 6.  Platelet-activating factor receptor.

Authors:  Satoshi Ishii; Takahide Nagase; Takao Shimizu
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

7.  Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

Authors:  R Quarck; B De Geest; D Stengel; A Mertens; M Lox; G Theilmeier; C Michiels; M Raes; H Bult; D Collen; P Van Veldhoven; E Ninio; P Holvoet
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

8.  Reduction in the extent of atherosclerosis in apolipoprotein E-deficient mice induced by electroporation-mediated transfer of the human plasma platelet-activating factor acetylhydrolase gene into skeletal muscle.

Authors:  Makoto Hase; Masashi Tanaka; Mitsuhiro Yokota; Yoshiji Yamada
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-09       Impact factor: 3.072

9.  Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.

Authors:  G Subbanagounder; N Leitinger; D C Schwenke; J W Wong; H Lee; C Rizza; A D Watson; K F Faull; A M Fogelman; J A Berliner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

10.  Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Bogdan Gugiu; Paul L Fox; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157

View more
  66 in total

Review 1.  Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

Authors:  Robert S Rosenson; Diana M Stafforini
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

Review 2.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

3.  Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells.

Authors:  Rui Chen; Erin Brady; Thomas M McIntyre
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

Review 4.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

5.  In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1+ BCP-ALL.

Authors:  Eleanor R C Fiedler; Arjun Bhutkar; Emily Lawler; Rana Besada; Michael T Hemann
Journal:  Blood Adv       Date:  2018-06-12

Review 6.  Lipid mediators in the regulation of endothelial barriers.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Tissue Barriers       Date:  2017-10-30

Review 7.  To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase.

Authors:  Gopal Kedihitlu Marathe; Chaitanya Pandit; Chikkamenahalli Lakshminarayana Lakshmikanth; Vyala Hanumanthareddy Chaithra; Shancy Petsel Jacob; Cletus Joseph Michael D'Souza
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

8.  HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms.

Authors:  Benjamin Emert; Yehudit Hasin-Brumshtein; James R Springstead; Ladan Vakili; Judith A Berliner; Aldons J Lusis
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

9.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

Review 10.  The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection.

Authors:  Theodoros Kelesidis; Vasiliki Papakonstantinou; Paraskevi Detopoulou; Elizabeth Fragopoulou; Maria Chini; Marios C Lazanas; Smaragdi Antonopoulou
Journal:  AIDS Rev       Date:  2015 Oct-Dec       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.